Abstract

The corona virus SARS-CoV-2 is the etiologic agent of the current pandemic outbreak of COVID-19 that is afflicting humankind through the whole globe since December of 2019 [1]. Huge efforts and resources are focused on many aspects of COVID-19 pathology and therapy, and indeed important advancements have been obtained in a relative short period of time. Following modest success with several intuitive and empirical therapeutic approaches (antiviral, antibiotics, anticoagulant, cortisone, immunosuppressive, cytokines) [2] most hopes are currently paying attention to a number immune based therapeutics such as several vaccines already entered in large clinical use [3]